PATENT CLAIM ANALYSIS

Application Number: 16112496
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["424", "145100"]

Abstract:
The number of acne lesions in a human subject is reduced by administering to the subject a pharmaceutical composition that includes a pharmaceutically acceptable carrier and a therapeutically effective amount of an agent that selectively binds IL-1α. Anxiety and other psychiatric conditions are also improved with this treatment.

Claim (Index 6):
The method of  claim 1 , wherein the pharmaceutical composition consists essentially of the pharmaceutically acceptable carrier and the anti-IL-1\u03b1 antibody.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 96.0
- Lexical Diversity: 1.19048
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13644976', '15252477', '15364597', '14030561', '15730218']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7523424817723632
- 35 USC 102 Novelty (BERT): 0.5391077540885314
- Combined Prediction Score: 0.73101900900398
- Mean Citation Score: 308.8594
- Max Citation Score: 380.55487
- Similarity Product: 321.2444660909188

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test